Megna Michael R bought KNSA
October 30, 2026 · Form 4 insider transaction
Megna Michael R bought 7,209 shares of Kiniksa Pharmaceuticals International, plc at $11.97 per share, a transaction worth $86.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,209
Price
$11.97
Total value
$86.3K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateOctober 30, 2026
Filing dateNovember 3, 2026
Shares owned after44,892
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.